The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecularly matched therapies identified by comprehensive genomic profiling before the first-line setting to provide alternative treatment outcomes in patients with solid tumors: 1-year follow-up of the prospective FIRST-Dx study.
 
Ryuji Hayashi
Honoraria - AstraZeneca; Chugai Pharma; Daiichi Sankyo/UCB Japan
Speakers' Bureau - Roche Diagnostics Solutions
Research Funding - Chugai Pharma; Taiho Pharmaceutical
 
Junichi Matsubara
Honoraria - DAIICHI SANKYO COMPANY, LIMITED
 
Kumi Mukai
No Relationships to Disclose
 
Masahiro Yoshioka
No Relationships to Disclose
 
Hidenori Kage
Research Funding - Konica Minolta (Inst)
 
Katsutoshi Oda
Honoraria - AstraZeneca; AstraZeneca/Merck; Chugai Pharma; Chugai Pharma; Konica Minolta; Takeda
Research Funding - AstraZeneca/Merck; Konica Minolta
 
Sadakatsu Ikeda
Honoraria - ACT Genomics; ACT Med; AstraZeneca; Bristol-Myers Squibb-Ono Pharmaceutical; Canon Medical System; Chugai Pharma; Guardant Health; MSD; Novartis; Roche; Taiho Pharmaceutical
Consulting or Advisory Role - Illumina
Research Funding - ACT Genomics (Inst); Canon Medical System (Inst); Hitachi (Inst)
Travel, Accommodations, Expenses - Guardant Health
 
Hiromichi Ebi
Honoraria - Amgen; Bristol-Myers Squibb Japan; Guardant Health AMEA; Incyte Japan; Merck Serono; Ono Pharmaceutical
Consulting or Advisory Role - Amgen; Merck Serono
Research Funding - Loxo/Lilly (Inst)
 
Kei Muro
Honoraria - Bristol-Myers Squibb; Daiichi Sankyo/UCB Japan; Lilly; MSD; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Chugai Pharma; Ono Pharmaceutical
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Chugai Pharma (Inst); MSD (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); PAREXEL International (Inst); PRA Health Sciences (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst)
 
Shinya Kajiura
Speakers' Bureau - DAIICHI SANKYO COMPANY, LIMITED
 
Reiko Ashida
No Relationships to Disclose
 
Masayuki Kitano
Honoraria - EA Pharma
Research Funding - Abbvie (Inst); Takeda (Inst)
 
Manabu Muto
Speakers' Bureau - Canon Medical System; Chugai Pharma; Daiichi Sankyo/Lilly; Illumina; Incyte Japan; Merck; MSD; Novartis; Olympus; Ono Pharmaceutical; Shionogi
Research Funding - Canon Medical System; Chugai Pharma; H.U. Group Holdings; Meiji Seika Kaisha; NTT; NTT Data; Taiho Pharmaceutical